First Time Loading...

Gland Pharma Ltd
NSE:GLAND

Watchlist Manager
Gland Pharma Ltd Logo
Gland Pharma Ltd
NSE:GLAND
Watchlist
Price: 1 710 INR 1% Market Closed
Updated: May 11, 2024

Intrinsic Value

Gland Pharma Ltd. manufactures pharmaceutical ingredients and injectable formulations. [ Read More ]

The intrinsic value of one GLAND stock under the Base Case scenario is 1 403.61 INR. Compared to the current market price of 1 710 INR, Gland Pharma Ltd is Overvalued by 18%.

Key Points:
GLAND Intrinsic Value
Base Case
1 403.61 INR
Overvaluation 18%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Gland Pharma Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling GLAND stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Gland Pharma Ltd

Provide an overview of the primary business activities
of Gland Pharma Ltd.

What unique competitive advantages
does Gland Pharma Ltd hold over its rivals?

What risks and challenges
does Gland Pharma Ltd face in the near future?

Summarize the latest earnings call
of Gland Pharma Ltd.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Gland Pharma Ltd.

Provide P/S
for Gland Pharma Ltd.

Provide P/E
for Gland Pharma Ltd.

Provide P/OCF
for Gland Pharma Ltd.

Provide P/FCFE
for Gland Pharma Ltd.

Provide P/B
for Gland Pharma Ltd.

Provide EV/S
for Gland Pharma Ltd.

Provide EV/GP
for Gland Pharma Ltd.

Provide EV/EBITDA
for Gland Pharma Ltd.

Provide EV/EBIT
for Gland Pharma Ltd.

Provide EV/OCF
for Gland Pharma Ltd.

Provide EV/FCFF
for Gland Pharma Ltd.

Provide EV/IC
for Gland Pharma Ltd.

Show me price targets
for Gland Pharma Ltd made by professional analysts.

What are the Revenue projections
for Gland Pharma Ltd?

How accurate were the past Revenue estimates
for Gland Pharma Ltd?

What are the Net Income projections
for Gland Pharma Ltd?

How accurate were the past Net Income estimates
for Gland Pharma Ltd?

What are the EPS projections
for Gland Pharma Ltd?

How accurate were the past EPS estimates
for Gland Pharma Ltd?

What are the EBIT projections
for Gland Pharma Ltd?

How accurate were the past EBIT estimates
for Gland Pharma Ltd?

Compare the revenue forecasts
for Gland Pharma Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Gland Pharma Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Gland Pharma Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Gland Pharma Ltd compared to its peers.

Compare the P/E ratios
of Gland Pharma Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Gland Pharma Ltd with its peers.

Analyze the financial leverage
of Gland Pharma Ltd compared to its main competitors.

Show all profitability ratios
for Gland Pharma Ltd.

Provide ROE
for Gland Pharma Ltd.

Provide ROA
for Gland Pharma Ltd.

Provide ROIC
for Gland Pharma Ltd.

Provide ROCE
for Gland Pharma Ltd.

Provide Gross Margin
for Gland Pharma Ltd.

Provide Operating Margin
for Gland Pharma Ltd.

Provide Net Margin
for Gland Pharma Ltd.

Provide FCF Margin
for Gland Pharma Ltd.

Show all solvency ratios
for Gland Pharma Ltd.

Provide D/E Ratio
for Gland Pharma Ltd.

Provide D/A Ratio
for Gland Pharma Ltd.

Provide Interest Coverage Ratio
for Gland Pharma Ltd.

Provide Altman Z-Score Ratio
for Gland Pharma Ltd.

Provide Quick Ratio
for Gland Pharma Ltd.

Provide Current Ratio
for Gland Pharma Ltd.

Provide Cash Ratio
for Gland Pharma Ltd.

What is the historical Revenue growth
over the last 5 years for Gland Pharma Ltd?

What is the historical Net Income growth
over the last 5 years for Gland Pharma Ltd?

What is the current Free Cash Flow
of Gland Pharma Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Gland Pharma Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Gland Pharma Ltd

Current Assets 59.7B
Cash & Short-Term Investments 21.4B
Receivables 14.6B
Other Current Assets 23.6B
Non-Current Assets 43.2B
Long-Term Investments 1.2B
PP&E 34.1B
Intangibles 6.1B
Other Non-Current Assets 1.8B
Current Liabilities 15.4B
Accounts Payable 9.8B
Other Current Liabilities 5.6B
Non-Current Liabilities 4.5B
Long-Term Debt 1.5B
Other Non-Current Liabilities 3B
Efficiency

Earnings Waterfall
Gland Pharma Ltd

Revenue
49.1B INR
Cost of Revenue
-19.4B INR
Gross Profit
29.7B INR
Operating Expenses
-21.2B INR
Operating Income
8.5B INR
Other Expenses
-1.9B INR
Net Income
6.6B INR

Free Cash Flow Analysis
Gland Pharma Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

GLAND Profitability Score
Profitability Due Diligence

Gland Pharma Ltd's profitability score is 60/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Year Average ROIC
Positive Operating Income
Exceptional Revenue Growth Forecast
60/100
Profitability
Score

Gland Pharma Ltd's profitability score is 60/100. The higher the profitability score, the more profitable the company is.

GLAND Solvency Score
Solvency Due Diligence

Gland Pharma Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Long-Term Solvency
Negative Net Debt
99/100
Solvency
Score

Gland Pharma Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

GLAND Price Targets Summary
Gland Pharma Ltd

Wall Street analysts forecast GLAND stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GLAND is 1 844.36 INR with a low forecast of 1 141.3 INR and a high forecast of 3 276 INR.

Lowest
Price Target
1 141.3 INR
33% Downside
Average
Price Target
1 844.36 INR
8% Upside
Highest
Price Target
3 276 INR
92% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

GLAND Price
Gland Pharma Ltd

1M 1M
-2%
6M 6M
+4%
1Y 1Y
+24%
3Y 3Y
-40%
5Y 5Y
-6%
10Y 10Y
-6%
Annual Price Range
1 710
52w Low
893.55
52w High
2 138
Price Metrics
Average Annual Return 11.23%
Standard Deviation of Annual Returns 62.99%
Max Drawdown -79%
Shares Statistics
Market Capitalization 281.6B INR
Shares Outstanding 164 700 800
Percentage of Shares Shorted
N/A

GLAND Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Gland Pharma Ltd Logo
Gland Pharma Ltd

Country

India

Industry

Pharmaceuticals

Market Cap

281.6B INR

Dividend Yield

0%

Description

Gland Pharma Ltd. manufactures pharmaceutical ingredients and injectable formulations. The company is headquartered in Hyderabad, Telangana. The company went IPO on 2020-11-20. The firm provides a range of injectables including vials, ampoules, pre-filled syringes, lyophilized vials, dry powders, infusions and ophthalmic solutions. The company provides contract development and manufacturing services, such as evaluation of development needs, identifying application program interface (API) sources, analytical method development, formulation development and product/technology know-how; and manufacturing of registration batches, studies, dossier compilation for regulatory submission and commercial production. The Company’s therapeutic products categories include Anti Malarials, Anti-Infectives, Anti-Neoplastics, Blood Related, Cardiac, Gastrointestinal, Gynaecological, Hormones, Neuro / Cns Ophthal / Otologicals, Pain/Analgesics, Respiratory and Vitamins / Minerals / Nutrients.

Contact

TELANGANA
Hyderabad
Survey No. 143-148, 150 & 151, Near Gandimaisamma 'X' Roads, D.P. Pally, Dundigal Gandimaisamma Mandal Medchal-Malkajgiri District
+914030510999
http://www.glandpharma.com/

IPO

2020-11-20

Employees

3 961

Officers

MD, CEO & Executive Director
Mr. Srinivas Sadu
Chief Financial Officer
Mr. Ravi Shekhar Mitra
Company Secretary & Compliance Officer
Mr. Sampath Kumar Pallerlamudi
Chief Operating Officer
Mr. Prakash Vithal Baliga
Vice President of Strategy & Investments
Mr. Ankit Gupta
Vice President of Investor Relations
Mr. Sumanta Bajpayee
Show More
Head of Domestic Marketing
Mr. Surinder Koul
Deputy General Manager of Human Resources
Ms. Shilpi Sahay
Senior Vice President of R&D
Dr. Surapanini Sridevi
Show Less

See Also

Discover More
What is the Intrinsic Value of one GLAND stock?

The intrinsic value of one GLAND stock under the Base Case scenario is 1 403.61 INR.

Is GLAND stock undervalued or overvalued?

Compared to the current market price of 1 710 INR, Gland Pharma Ltd is Overvalued by 18%.